Vinge receives top ranking in intellectual property law

Vinge's IP group is once again placed at the top of the recently released IAM Patent 1000 ranking. Håkan Borgenhäll, Malin Malm Waerme, Åsa Hellstadius and Stojan Arnerstål also receive individual mentions.

The top ranking by one of the world's leading ranking institutes is gratifying, and shows Vinge's unrivalled position in patent litigation. It is particularly pleasing that Vinge's strong position in life sciences is recognised. The individual assessments reflect the strengths of the IP team, where we offer unique expertise as well as breadth and experience. This position bodes well for the future, and we would like to give special thanks to our clients for excellent teamwork in complex cases that have driven the law forward.

says Richard Wessman, partner and head of Vinge's IP group.

IAM Patent 1000's comments summarised:

Vinge's forward-thinking patent group has made a name for itself in the Swedish IP scene for its outstanding skill set in the life sciences industry, where it represents the likes of Merck, Sharp & Dohme (MSD) and other pharmaceutical companies.

Håkan Borgenhäll and Malin Malm Waerme bring their expertise to the MSD matter – an invalidity action brought by KRKA against one of MSD's SPCs for its anti-diabetic drug Janumet. "Håkan is a fierce and thorough practitioner. He has a panoramic perspective and a solid understanding of technology, which allows him to uncover important details that produce favourable results." "Malin is a brilliant attorney who excels in fostering long-lasting client relationships and has a robust grasp of complex legal issues spanning the complete IP domain."

Making her debut in the IAM Patent 1000 this year, "Åsa Hellstadius is a bright, hardworking individual. She draws on her deep understanding of intellectual property to navigate intricate legal and strategic situations."

Promoted to counsel in 2022, Stojan Arnerstål is a transactional ace and embodies the breadth of mandates entrusted to the firm. Lately, he has been assisting biopharmaceutical company Cinclus Pharma Holding to accelerate their commercialisation strategy and broaden their shareholder base.

About the ranking

The ranking is based on client surveys, statements from opposing counsel and reviews of submissions and reference interviews where IAM assesses which lawyers are considered to be of the highest quality in their advice.

Read more about IAM Patent 1000 and the full review of Vinge